Trial Profile
Phase I trial of AVN 322.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2011
Price :
$35
*
At a glance
- Drugs AVN 322 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
- 09 Feb 2010 New trial record